NCT03296540View on ClinicalTrials.gov

CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI

PHASE4CompletedINTERVENTIONAL
Enrollment

729

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

May 1, 2021

Study Completion Date

May 1, 2021

Conditions
Cardiovascular Diseases
Interventions
DRUG

Prasugrel (Crushed tablets)

loading dose of 6 crushed tablets 10mg Prasugrel

DRUG

Prasugrel (Integral tablets)

loading dose of 6 integral tablets of 10mg Prasugrel

Trial Locations (2)

3015 CE

Erasmus Medical Center, Rotterdam

3079 DZ

Maasstadziekenhuis, Rotterdam

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

MicroPort Orthopedics Inc.

INDUSTRY

collaborator

Daiichi Sankyo

INDUSTRY

collaborator

Research Maatschap Cardiologen Rotterdam Zuid

OTHER

lead

Maasstad Hospital

OTHER

NCT03296540 - CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI | Biotech Hunter | Biotech Hunter